Wespran is proud to announce the successful closing of our first capital raise with General Inception (GI), a leading transatlantic biotech venture firm headquartered in San Francisco, CA, USA. GI partners with visionary founders to accelerate deeptech ventures with global impact.

This investment marks a pivotal step in Wespran’s journey — enabling us to fast-track our R&D, strengthen operations, and bring our enzymatic CO₂ upcycling technology closer to industrial deployment.